Literature DB >> 11316101

Effects of early postfiltration ocular hypotony on visual acuity, long-term intraocular pressure control, and posterior segment morphology.

O Schwenn1, I Kersten, H B Dick, H Müller, N Pfeiffer.   

Abstract

PURPOSE: To determine whether hypotony after filtration surgery has any influence on visual acuity and intraocular pressure (IOP) lowering. PATIENTS AND METHODS: We prospectively investigated 43 eyes of 43 patients undergoing trabeculectomy without the use of antimetabolites for 12 months.
RESULTS: The lowest postoperative IOP valued 4.9 +/- 3.6 mm Hg (range, 0-14 mm Hg). It correlated statistically significant with the IOP 6 weeks (P = 0.016), 6 months (P = 0.009), and 1 year after surgery (P = 0.027). Eyes with a deterioration of visual acuity 6 weeks after surgery had undergone a stronger postoperative hypotony (correlation with lowest postoperative IOP, P = 0.035). The mean period with an IOP less than 5 mm Hg was 3.5 +/- 8.0 days, and the mean period with an IOP less than 10 mm Hg lasted 45.4 +/- 68.8 days (range, 0-276 days). A hypotony score based on IOP and duration of hypotony was introduced. A correlation was detected between morphologic signs of hypotony, such as tiny retinal folds, at the 6-month follow-up and the duration of hypotony (P = 0.029) and hypotony score (P = 0.001).
CONCLUSIONS: Hypotony after filtration surgery may decrease visual acuity in the early postoperative period. Conversely, early postoperative hypotony correlated with better long term IOP control. There was no deleterious effect on visual acuity after 6 months.

Entities:  

Mesh:

Year:  2001        PMID: 11316101     DOI: 10.1097/00061198-200104000-00003

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  Effects of early postoperative complications and the location of trephined block on long-term intraocular pressure control after trabeculectomy.

Authors:  Pia Ehrnrooth; Ilkka Lehto; Päivi Puska; Leila Laatikainen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-29       Impact factor: 3.117

Review 2.  [Revision after filtration surgery].

Authors:  A G M Jünemann; R Rejdak; B Hohberger
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

3.  One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma.

Authors:  Chengguo Zuo; Shufen Lin; Keling Wu; Ruowen Gong; Yafen Liu; Mingkai Lin; Jian Ge
Journal:  Int Ophthalmol       Date:  2019-01-24       Impact factor: 2.031

4.  Risk factors for flat anterior chamber after glaucoma filtration surgery.

Authors:  Xiang-Ji Li; Richard Filek; Xiang-Ge He; Wei Wang; Hong Liu; Lian He; Yu-Rong Tang; Lin Xie
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

5.  [Deep sclerectomy using a hyaluronate implant versus trabeculectomy. A comparison of two glaucoma operations using mitomycin C].

Authors:  O Schwenn; C Springer; A Troost; S H Yun; N Pfeiffer
Journal:  Ophthalmologe       Date:  2004-07       Impact factor: 1.059

6.  Is post-trabeculectomy hypotony a risk factor for subsequent failure? A case control study.

Authors:  Sarah E Benson; Kaveri Mandal; Catey V Bunce; Scott G Fraser
Journal:  BMC Ophthalmol       Date:  2005-04-05       Impact factor: 2.209

7.  Stabilization of macular, peripapillary and papillary vascular parameters after XEN and trabeculectomy visualized by the optical coherence tomography angiography.

Authors:  Emanuel Reitemeyer; Milena Pahlitzsch; Anna Cornelius; Daniel Pilger; Sibylle Winterhalter; Anna-Karina B Maier
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

8.  A New Method for Revision of Encapsulated Blebs after Trabeculectomy: Combination of Standard Bleb Needling with Transconjunctival Scleral Flap Sutures Prevents Early Postoperative Hypotony.

Authors:  Panagiotis Laspas; Philipp David Culmann; Franz Hermann Grus; Verena Prokosch-Willing; Alicia Poplawksi; Norbert Pfeiffer; Esther Maria Hoffmann
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.